Evidence map›Paper›PMID 31773883›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2020

Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.

Kazuomi Kario, Yook-Chin Chia, Apichard Sukonthasarn, Yuda Turana, Jinho Shin, Chen-Huan Chen, Peera Buranakitjaroen, Jennifer Nailes, Satoshi Hoshide, Saulat Siddique and 13 more

Abstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Blood pressure status, JSH 2019-based control rate, and associated factors among community-dwelling adults: The NOSE study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  3. Review
  4. Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  5. Article
  6. Article
  7. Observational
  8. Latest hypertension research to inform clinical practice in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  9. Review
  10. Perspectives of renal denervation from hypertension to heart failure in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  11. Seasonal variation in blood pressure: current evidence and recommendations for hypertension management.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Review
  12. Article
  13. Nighttime home blood pressure as a mediator of N-terminal pro-brain natriuretic peptide in cardiovascular events.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Isolated systolic hypertension in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Review
  18. The feasibility of polypill for cardiovascular disease prevention in Asian Population.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Review
  19. Hypertension in a multi-ethnic Asian population of Singapore.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Review
  20. Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
Yook-Chin ChiaDepartment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.ORCID 0000-0003-1995-0359
Apichard SukonthasarnCardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Yuda TuranaFaculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.ORCID 0000-0001-6706-6504
Chen-Huan ChenDepartment of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Peera BuranakitjaroenDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-4710-2413
Jennifer NailesUniversity of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines.
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0001-7541-5751
Saulat SiddiqueFatima Memorial Hospital, Lahore, Pakistan.ORCID 0000-0003-1294-0430
Jorge SisonSection of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines.
Arieska Ann SoenartaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.
Guru Prasad SogunuruMIOT International Hospital, Chennai, India.
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore.
Boon Wee TeoDivision of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.ORCID 0000-0002-4911-8507
Yu-Qing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.
Huynh Van MinhDepartment of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue City, Vietnam.
Naoko TomitaniDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Tomoyuki KabutoyaDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Narsingh VermaDepartment of Physiology, King George's Medical University, Lucknow, India.
Tzung-Dau WangDepartment of Internal Medicine, Cardiovascular Center and Division of Cardiology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan.
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network was set up to improve the management of hypertension in Asia with the ultimate goal of achieving "zero" cardiovascular events. Asia is a diverse continent, and the prevalence of hypertension has increased over the last 30 years. There are a number of Asia-specific features of hypertension and hypertension-related cardiovascular complications, which means that a region-specific approach is needed. White-coat hypertension will become more of an issue over time as Asian populations age, and masked hypertension is more prevalent in Asian than in Western countries. Identifying and treating masked hypertension is important to reduce cardiovascular risk. Abnormal patterns of blood pressure (BP) variability common in Asia include exaggerated early morning BP surge and nocturnal hypertension. These are also important cardiovascular risk factors that need to be managed. Home blood pressure monitoring (HBPM) is an important tool for detecting white-coat and masked hypertension, and monitoring BP variability, and practices in Asia are variable. Use of HBPM is important given the Asia-specific features of hypertension, and strategies are needed to improve and standardize HBPM usage. Development of HBPM devices capable of measuring nocturnal BP along with other information and communication technology-based strategies are key developments in the widespread implementation of anticipation medicine strategies to detect and prevent cardiovascular events in patients with hypertension. Region-wide differences in hypertension prevalence, control, and management practices in Asia highlight the importance of information sharing to facilitate best practices.

Indexed as

HypertensionAsiaBlood PressureBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryHumansAsiadiversityHope Asiahypertensioninitiative

Identifiers

PMID31773883
PMCPMC8029896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.